3/31/2026IMPACT Therapeutics Renews Hong Kong IPO Push With Updated Filing

3/31/2026Syneron Bio Closes Major Series B to Advance AI-Driven Macrocyclic Pep...

3/31/2026Biocytogen Licenses RenNano® Antibody Discovery Platform to Taisho Ph...

3/31/2026NHSA Deepens Dialogue With MNC Pharma on Innovation Drug Value and Rea...

3/31/2026NMPA Moves to Strengthen China's Conditional Drug Approval Framework

3/31/2026CK Life Sciences Moves to Fast-Track China Cancer Vaccine Development ...

3/31/2026Huahui Launches World's First Approved Hepatitis D Antibody Drug in Ch...

3/31/2026Connect Biopharma Reports Promising Late-Stage China Results for Eczem...

3/31/2026Braveheart Bio Posts Promising Mid-Stage China Data for HCM Drug Licen...

3/31/2026China's Innovative Drug Out-Licensing Nears Half of 2025 Total in Firs...

3/31/2026Santen Accelerates China Strategy by Moving Earlier Into Global Ophtha...

More>>

3/25/2026IQVIA Report Highlights Rising Use and Intensifying Competition in Chi...

3/24/2026Global Pharma Ramps Up China Investment as 15th Five-Year Plan Priorit...

3/17/2026US Reshoring Push Clouds Long-Term Outlook for China's Contract Drugma...

3/17/2026China to Grant Market and Data Exclusivity for Innovative Drugs for th...

3/13/2026China Private Biotech Financing Slows in February but Larger Deals Sig...

3/12/2026China's Labs Race for the Next First-in-Class Breakthrough

3/10/2026China Challenges High-Priced Gene Therapies with Lower-Cost Alternativ...

3/10/2026China Biotech Dealmaking Defies Seasonal Slowdown as February Licensin...

3/10/2026US Weighs Policy Measures to Address China Biotech Competition

3/9/2026China Biotech Financing Rebounds in Early 2026 as RNA Deals and Global...

3/4/2026China Biotech Outlicensing Surges Past US$52 Billion in Early 2026

More>>